Page last updated: 2024-12-05

cycloheptanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cycloheptanone is a seven-membered cyclic ketone that has been studied for its various applications. It is a colorless liquid with a pungent odor. Cycloheptanone is a versatile starting material for the synthesis of various organic compounds, including pharmaceuticals and other fine chemicals. Its synthesis typically involves the oxidation of cycloheptanol or the ring-closing metathesis of unsaturated precursors. The compound exhibits interesting biological activities, including antimicrobial and anti-inflammatory effects. Cycloheptanone is also used as an intermediate in the production of polymers, resins, and other industrial chemicals. Research efforts have focused on exploring its potential in various fields, including medicinal chemistry, materials science, and organic synthesis.'

cycloheptanone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10400
CHEMBL ID18607
SCHEMBL ID6077
MeSH IDM0040462

Synonyms (37)

Synonym
qh80295937 ,
unii-qh80295937
LS-13306
ai3-09538
hsdb 2819
nsc 9471
einecs 207-937-6
suberone
502-42-1
ketoheptamethylene
nsc-9471
nsc9471
wln: l7vtj
suberon
cycloheptanone
ketocycloheptane
inchi=1/c7h12o/c8-7-5-3-1-2-4-6-7/h1-6h
cycloheptanone, 99%
AKOS000118914
CHEMBL18607 ,
cycloheptanon
bdbm50028831
FT-0624172
cycloheptanone [mi]
SCHEMBL6077
cyclo-heptanone
DTXSID8060113
mfcd00004159
J-520144
F0001-1310
cycloheptanone, 98+%
Q413525
STL199038
AMY3995
D89253
EN300-19194
Z104473100
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)IC50 (µMol)510.00000.96005.32008.0000AID155162
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (2)

Processvia Protein(s)Taxonomy
methylationPhenylethanolamine N-methyltransferaseBos taurus (cattle)
epinephrine biosynthetic processPhenylethanolamine N-methyltransferaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
phenylethanolamine N-methyltransferase activityPhenylethanolamine N-methyltransferaseBos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID155162Inhibitory activity against phenylethanolamine N-methyl-transferase1981Journal of medicinal chemistry, Jan, Volume: 24, Issue:1
Importance of the aromatic ring in adrenergic amines. 5. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of hydrophobic and steric interactions.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (6.25)18.7374
1990's2 (12.50)18.2507
2000's7 (43.75)29.6817
2010's6 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.14 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index72.10 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]